Extractionless high-performance liquid chromatographic method for the simultaneous determination of piroxicam and 5'-hydroxypiroxicam in human plasma and urine

J Chromatogr B Biomed Appl. 1995 Nov 3;673(1):142-6. doi: 10.1016/0378-4347(95)00248-h.

Abstract

A simple and rapid (extractionless) high-performance liquid chromatographic method with UV detection, at 330 nm, was developed for the simultaneous determination of piroxicam and its major metabolite, 5'-hydroxypiroxicam, in human plasma and urine. Acidified plasma and alkali-treated urine samples are used and naproxen is added as internal standard. The separation is performed at 40 degrees C on a C18 Spherisorb column with acetonitrile--0.1 M sodium acetate (33:67, v/v, pH 3.3) as mobile phase. The retention time is 2.2 min for 5'-hydroxypiroxicam, 2.6 min for piroxicam and 3.2 min for naproxen. The detection limit is 0.05 micrograms/ml using a 100-microliters loop.

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / analysis*
  • Anti-Inflammatory Agents, Non-Steroidal / blood
  • Anti-Inflammatory Agents, Non-Steroidal / urine
  • Chromatography, High Pressure Liquid* / methods
  • Humans
  • Naproxen / analysis
  • Piroxicam / analogs & derivatives*
  • Piroxicam / analysis*
  • Piroxicam / blood
  • Piroxicam / pharmacokinetics
  • Piroxicam / urine
  • Reproducibility of Results
  • Spectrophotometry

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Piroxicam
  • Naproxen
  • 5'-hydroxypiroxicam